Workboat Indexes

Relay Therapeutics Inc (NQ: RLAY )

9.000 -0.510 (-5.36%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 10, 2024 Add to My Watchlist

Price and Volume

Volume	6,405,184
Open	10.00
Bid (Size)	8.860 (1)
Ask (Size)	8.970 (6)
Prev. Close	9.510
Today's Range	8.075 - 10.13
52wk Range	5.700 - 12.14
Shares Outstanding	121,613,181
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

Today 20:21 EDT

From Relay Therapeutics, Inc.

Via GlobeNewswire

Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market

Today 14:50 EDT

Relay Therapeutics shares interim data for RLY-2608 from the ReDiscover study, showing a 57% clinical benefit rate. Oppenheimer downgrades Relay Therapeutics from Outperform to Perform, citing concerns...

Via Benzinga

Performance

YTD	-24.08%	-24.08%
1 Month	+38.25%	+38.25%
3 Month	+24.48%	+24.48%
6 Month	-3.74%	-3.74%
1 Year	-8.16%	-8.16%

More News

AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th

Today 11:37 EDT

Via Talk Markets

This Johnson Controls International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Today 10:03 EDT

Via Benzinga

Expert Ratings For Relay Therapeutics

August 07, 2024

Via Benzinga

Expert Ratings For Relay Therapeutics

July 17, 2024

Via Benzinga

Dow Jumps Over 1% Following Last Week's Selloff: Investor Sentiment Improves, But Fear & Greed Index Remains In 'Fear' Zone

Today 2:12 EDT

Via Benzinga

Relay Therapeutics Announces Proposed Public Offering of Common Stock

September 09, 2024

From Relay Therapeutics, Inc.

Via GlobeNewswire

Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher

September 09, 2024

Via Benzinga

Nasdaq Surges Over 1%; US Wholesale Inventories Rise 0.2% In July

September 09, 2024

Via Benzinga

Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients

September 09, 2024

Via Benzinga

Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday

September 09, 2024

Via Benzinga

US Stocks Higher; Dow Surges Over 200 Points

September 09, 2024

Via Benzinga

Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival

September 09, 2024

From Relay Therapeutics, Inc.

Via GlobeNewswire

Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024

September 06, 2024

From Relay Therapeutics, Inc.

Via GlobeNewswire

Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone!

September 05, 2024

Via Talk Markets

Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week

August 27, 2024

Via Talk Markets

RLAY Stock Earnings: Relay Therapeutics Beats EPS for Q2 2024

August 06, 2024

Via InvestorPlace

Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights

August 06, 2024

From Relay Therapeutics, Inc.

Via GlobeNewswire

Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024

July 30, 2024

From Relay Therapeutics, Inc.

Via GlobeNewswire

AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD

July 30, 2024

Via Talk Markets

These 7 AI Stocks Were Major Movers On Monday/Tuesday - Here's Why

July 24, 2024

Via Talk Markets

AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD

July 18, 2024

Via Talk Markets

Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD

July 14, 2024

Via Talk Markets

Clinical-Stage BioTech Drug Stocks Declined 13% In June

July 01, 2024

Via Talk Markets

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.